Healthcare
35 companies listed on NSE in this sector
Total revenue reached INR 8.8 Cr in H1 FY24. The company focuses on multi-specialty healthcare services, including PMJAY, Cash, and Mediclaim patients. Management targets a revenue...
Consolidated revenue grew 15% YoY in FY25. Healthcare services segment, back-end pharmacy (AHL), and diagnostics/retail health were primary drivers. Pharmacy distribution grew 16% ...
Revenue from operations grew 108.2% YoY to INR 135.7 Cr in FY25 from INR 65.16 Cr in FY24. The revenue mix is dominated by Turnkey Infrastructure Projects at 90% (INR 122.13 Cr), f...
Revenue from operations grew 13.8% YoY to INR 274.70 Cr in Q2 FY26. Flagship Gurugram facility remains the primary driver. Asset-light models Artemis Daffodil and Artemis Lite cont...
The core Hospitals and Clinics segment, which contributes 94% of total revenue, grew 10% YoY in Q2 FY26 to INR 1,160 Cr. Aster Labs revenue grew 15% YoY in Q2 FY26, while the Pharm...
Consolidated revenue from operations grew 28.5% YoY to INR 1,711 Cr in FY25. In H1 FY26, revenue reached INR 986 Cr, a 20.1% increase YoY. Mature facilities contributed 74.6% of H1...
Consolidated revenue grew 10.5% YoY in FY25 to INR 2,461.4 Cr. In Q2 FY26, revenue reached INR 731 Cr, a 10.7% increase YoY, while H1 FY26 revenue stood at INR 1,400 Cr, up 11%. Th...
Hospital business revenue grew 19.3% YoY to INR 1,974 Cr in Q2 FY26, while the Diagnostics business (Agilus) grew 7.3% YoY to INR 400 Cr. For H1 FY26, Hospital revenue increased 19...
Revenue from operations grew by 11% YoY in H1 FY26 to INR 226 Cr, compared to INR 204 Cr in H1 FY25. Q2 FY26 revenue grew by 12.5% YoY to INR 118.9 Cr. The growth is primarily driv...
Matured hospitals (Gurugram, Indore, Ranchi) grew 10.6% YoY to INR 26,119 million in FY25; Developing hospitals (Lucknow, Patna) grew 10% YoY to INR 10,940 million. Outpatient phar...
Consolidated operating income grew 12.8% YoY to INR 1,912.1 Cr in FY2024 from INR 1,694.4 Cr in FY2023. The Milann (fertility) segment saw a significant revenue increase from INR 9...
Total income from operations grew to INR 1,356.36 Cr in FY25 from INR 1,244.70 Cr in FY24, representing a YoY increase of 8.97%. Revenue per patient increased by 2% to INR 202,869,...
Total revenue grew 18.0% in FY2025 to INR 1,261.5 Cr, following a 19.8% growth in FY2024 to INR 1,069.5 Cr. H1 FY2025 saw 14.0% growth driven by the ramp-up of Pune and Indore hosp...
Healthcare and Education are the primary segments. Profit Before Tax (PBT) for the half-year ended September 30, 2025, grew 20.42% YoY to INR 154.27 Cr from INR 128.11 Cr in the pr...
Consolidated revenue grew 21% YoY to INR 3,039 Cr in FY25 from INR 2,503 Cr in FY24. Growth was driven by a 22% CAGR between FY20-24, supported by bed additions and improved ARPOBD...
Overall revenue grew 11% YoY to INR 206 Cr in Q2 FY26. The retail/D2C segment showed a significant 60% QoQ growth, contributing 8% to total revenue in H1 FY26. B2G (Business-to-Gov...
Laboratory business revenue grew 28% YoY to INR 94.0 Cr in H1 FY26. Aligner solutions (Bizdent) grew 7% YoY to INR 38.8 Cr. Scanner sales saw a massive jump of 94.7% YoY in Q2 FY26...
Revenue from operations for FY21 was INR 32.37 Cr, representing a 20.18% decline from INR 40.55 Cr in FY20, primarily due to pandemic-related disruptions. However, Q4 FY21 showed a...
The company operates in a single segment: healthcare services and products. Consolidated revenue for H1 FY26 was INR 23.92 Cr, representing a 2.57% decline compared to INR 24.55 Cr...
Standalone revenue from operations grew 13.8% to INR 2,663.60 Cr in FY25. Healthcare services contributed INR 2,411.33 Cr (90.5% of standalone revenue), Operation and Management (O...
Metropolis delivered a broad-based revenue growth of 23% YoY in Q2 FY26. Volume growth is projected to remain in the double-digit range of 10% to 11% for the remainder of the fisca...
100% of revenue is derived from the manufacturing segment. Total revenue for FY 2024-25 was INR 167.77 Cr, representing a 15.95% decline from INR 199.61 Cr in FY 2023-24.
The core hospital segment saw a significant jump in revenue following the commissioning of the Camana Bay hospital, with revenue increasing from $25 million to $40 million (60% gro...
Total revenue from operations grew 69.04% YoY to INR 46.03 Cr in FY25 from INR 27.23 Cr in FY24. For H1 FY26, revenue reached INR 39.33 Cr, representing a 38.76% sequential increas...
The company operates in a single segment (Healthcare and Diagnostics). Total revenue for FY25 was INR 24.53 Cr, representing a marginal growth of 1.45% compared to INR 24.18 Cr in ...
Consolidated revenue grew 5.3% YoY to INR 847.1 Cr in H1 FY26. Domestic revenue showed strong momentum, growing 17-18% YoY in Q2 and H1 FY26. Within the domestic market, the privat...
Consolidated total income grew by 17.46% YoY to INR 15,668.74 million in FY 2024-25, driven by a 12.15% increase in In-patient volumes (98,395) and an 11.72% rise in Out-patient vo...
Consolidated revenue from operations grew by 104.55% YoY to INR 20.47 Cr for the half-year ended September 30, 2025, compared to INR 10.01 Cr in the previous year's corresponding p...
Consolidated revenue grew 5.5% YoY to INR 289.9 Cr in Q2 FY26. Segmental growth: Shalby Hospitals/Pharma/Franchise grew to INR 234.5 Cr (80.9% of total), Shalby MedTech (Implants) ...
Consolidated revenue grew 15% YoY to INR 251.28 Cr in FY25 from INR 218.52 Cr in FY24. H1 FY26 revenue reached INR 151.43 Cr, an 18.5% increase over H1 FY25 revenue of INR 127.74 C...
Pathology revenue grew 24% YoY in Q2 FY26, while the Radiology business saw a modest 3% YoY growth. Within Pathology, the Franchisee business grew 20% YoY (INR 125 Cr) and the Part...
Consolidated operating income grew 14.01% YoY from INR 48.75 Cr in FY 2024 to INR 55.58 Cr in FY 2025. Standalone revenue is derived from Medical Tour Operations, Health Consultanc...
In H1 FY26, total revenue reached INR 49.94 Cr, a 19.48% YoY increase. For FY24, Hospital Activity revenue was INR 21.73 Cr (up 9.3% from INR 19.87 Cr), while Sale of Products cont...
Consolidated revenue for Q2 FY26 reached INR 202 Cr, representing a 10.2% YoY growth and a 7.2% QoQ increase. For H1 FY26, revenue stood at INR 390 Cr, a 15% YoY growth. This growt...
Consolidated revenue grew 31.3% YoY to INR 880.5 Cr in FY25. In Q2 FY26, revenue reached INR 279.4 Cr, up 28% YoY. Newer hospitals were the primary growth drivers with a 110% YoY i...